Amgen (AMGN) Phase 1 Data Confirms Expected Response Rate - BMO Capital
Tweet Send to a Friend
BMO Capital analyst Do Kim reiterated an Outperform rating on Amgen (NASDAQ: AMGN) after AMG 510 Phase 1 data released ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
